ArticleFrontiers in bioengineering and biotechnology2025
Pulsed electromagnetic field prevents lumbar bone loss in orchiectomy mice without altering systemic iron metabolism.
Article in Frontiers in bioengineering and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The therapeutic efficacies of pulsed electromagnetic fields (PEMFs) for postmenopausal osteoporosis are well established; however, their effects on male osteoporosis remain uncertain. Osteoporosis development is often associated with dysregulation of systemic iron metabolism. This study aimed to investigate the therapeutic effects of PEMFs on orchiectomy (ORX)-induced osteoporosis in mice and determine whether the mechanism involves regulation of systemic iron metabolism. Methods: Twenty-four 10-week-old male C57BL/6J mice were divided into the sham, ORX, and ORX + PEMF groups (n = 8 each). The ORX + PEMF group received PEMF treatment (15 Hz, peak of 3.82 mT, 40 min/d for 2 months) starting 2 weeks post-surgery. The bone loss was assessed via micro-computed tomography, biomechanical testing, dynamic histomorphometry, and TRAP staining. The systemic iron metabolism was evaluated via Prussian blue staining, atomic absorption spectrometry, and serum ELISA (hepcidin, ferritin). Results: PEMF treatment partially prevented ORX-induced bone loss in the lumbar spine, as evidenced by significant improvements in the microstructure and mechanical properties of the bone, along with partially restored bone formation and suppressed bone resorption compared to the untreated ORX mice. However, PEMF application showed no significant protective effects on the femoral bone microstructure or cortical parameters. Crucially, PEMF treatment did not alter the markers of systemic iron metabolism, meaning that no changes were observed in the tissue iron deposition, iron content, serum ferritin level, serum hepcidin level, or liver hepcidin expression. Conclusion: PEMF therapy exerts site-specific protective effects against ORX-induced osteoporosis in the lumbar spine of male mice to partially restore bone formation and reduce resorption. This therapeutic efficacy is independent of any alterations in the systemic iron metabolism. The findings of this study support PEMF application as a potential physical therapy for male osteoporosis while highlighting the need for site-optimized strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.